Assignee
NEWGEN THERAPEUTICS INC
US·1 granted patent·6 pending applications·0 citations·filing 2012–2020
Top patents by PatentIndex Score
7 records- 0163US11524956B2Alkyne substituted quinazoline compound and methods of useNEWGEN THERAPEUTICS INC·Filed 2020·Granted Dec 13, 2022·0 cites·55 claims
- 0257US2019382382A1Alkyne substituted quinazoline compound and methods of useNEWGEN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0353US2018093975A1Alkyne substituted quinazoline compound and methods of useNEWGEN THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 0452US2018094010A1Tricyclic inhibitors of poly(adp-ribose)polymeraseNEWGEN THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 0551US2014221314A1Tricyclic inhibitors of poly(adp-ribose)polymeraseNEWGEN THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 0649US2017057984A1Tricyclic inhibitors of poly(adp-ribose)polymeraseNEWGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 0747US2016031860A1Alkyne substituted quinazoline compound and methods of useNEWGEN THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →